Spots Global Cancer Trial Database for visugromab
Every month we try and update this database with for visugromab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Neoadjuvant Immunotherapy in Combination With the Anti-GDF-15 Antibody Visugromab (CTL-002) for Treatment of Muscle Invasive Bladder Cancer | NCT06059547 | Bladder Cancer Adult Solid Tum... | Nivolumab Visugromab (CTL... Placebo | 18 Years - | CatalYm GmbH |